| Name | Walgreens #13758 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 6200 N Scottsdale Rd, Scottsdale, Arizona 85253 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (480) 822-6197 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Repligen Corporation today announced that the first patient has been enrolled in a pilot study to evaluate the ability of RG1068 to improve detection and characterization of pancreatic cancer in combination with contrast-enhanced magnetic resonance imaging (MRI) and computed tomography.
QLT Inc. welcomed the 6-month results from the Novartis-sponsored EVEREST study which were presented during a scientific review today by Novartis in Basel, Switzerland.
When a new tobacco-free policy was instituted at an Ohio women's substance abuse treatment center, both smokers and non-smokers were more likely to leave treatment early in the first few months after the policy change, a new study found.
Affinium Pharmaceuticals announced today the closing of its $15 million financing. Investors participating in the financing include all three of Affinium's Series A investors, SV Life Sciences, Genesis Capital Partners and Forward Ventures, along with the addition of the Ontario Emerging Technologies Fund (OETF) to the syndicate.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market preservative-free Methotrexate Injection, USP. APP currently manufactures Methotrexate Injection with preservative.
› Verified 4 days ago
| NPI Number | 1891093431 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #13758 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 6200 N Scottsdale Rd, Scottsdale, AZ 85253 |
| Phone Number | 480-822-6197 |
News Archive
Repligen Corporation today announced that the first patient has been enrolled in a pilot study to evaluate the ability of RG1068 to improve detection and characterization of pancreatic cancer in combination with contrast-enhanced magnetic resonance imaging (MRI) and computed tomography.
QLT Inc. welcomed the 6-month results from the Novartis-sponsored EVEREST study which were presented during a scientific review today by Novartis in Basel, Switzerland.
When a new tobacco-free policy was instituted at an Ohio women's substance abuse treatment center, both smokers and non-smokers were more likely to leave treatment early in the first few months after the policy change, a new study found.
Affinium Pharmaceuticals announced today the closing of its $15 million financing. Investors participating in the financing include all three of Affinium's Series A investors, SV Life Sciences, Genesis Capital Partners and Forward Ventures, along with the addition of the Ontario Emerging Technologies Fund (OETF) to the syndicate.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market preservative-free Methotrexate Injection, USP. APP currently manufactures Methotrexate Injection with preservative.
› Verified 4 days ago
News Archive
Repligen Corporation today announced that the first patient has been enrolled in a pilot study to evaluate the ability of RG1068 to improve detection and characterization of pancreatic cancer in combination with contrast-enhanced magnetic resonance imaging (MRI) and computed tomography.
QLT Inc. welcomed the 6-month results from the Novartis-sponsored EVEREST study which were presented during a scientific review today by Novartis in Basel, Switzerland.
When a new tobacco-free policy was instituted at an Ohio women's substance abuse treatment center, both smokers and non-smokers were more likely to leave treatment early in the first few months after the policy change, a new study found.
Affinium Pharmaceuticals announced today the closing of its $15 million financing. Investors participating in the financing include all three of Affinium's Series A investors, SV Life Sciences, Genesis Capital Partners and Forward Ventures, along with the addition of the Ontario Emerging Technologies Fund (OETF) to the syndicate.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market preservative-free Methotrexate Injection, USP. APP currently manufactures Methotrexate Injection with preservative.
› Verified 4 days ago
Accurate Care Chiropractic & Acupun Type: Medicare Supplier Location: 18261 N Pima Rd, Scottsdale, Arizona 85255 Phone: (602) 493-2228 | |
Albertsons Pharmacy #0197 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 11475 E Via Linda, Scottsdale, Arizona 85259 Phone: (480) 657-8968 | |
Osco Drug #2955 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2785 N Scottsdale Rd, Scottsdale, Arizona 85257 Phone: (480) 947-7574 | |
Osco Drug 966 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 6965 N Hayden Rd, Scottsdale, Arizona 85250 Phone: (480) 991-9557 | |
American Physical Medicine Type: Medicare Supplier Location: 8417 E Mcdowell Rd, Scottsdale, Arizona 85257 Phone: (480) 946-3399 |